Creative Biolabs Reinforces Rheumatic Disease Research by Comprehensive Autoantibody Service
Creative Biolabs introduces comprehensive NAA services and products covering a wide range of potential markers for rheumatic disease research. New York, USA – June 16, 2022 – The advent of biologic therapies, particularly antibody therapeutics, has revolutionized the pharmacological treatment of many rheumatic diseases. As the natural autoantibodies (NAAs) show strong associations with rheumatic disease […]







